Performance of LigAmp Assay for Sensitive Detection of Drug-Resistant Hepatitis B Virus Minor Variants in Comparison with Standard Nucleotide Sequencing

[1]  A. M. Ismail,et al.  Lamivudine Monotherapy in Chronic Hepatitis B Patients from the Indian Subcontinent: Antiviral Resistance Mutations and Predictive Factors of Treatment Response , 2014, Molecular Diagnosis & Therapy.

[2]  Jiming Zhang,et al.  Detection of lamivudine- or adefovir-resistant hepatitis B virus mutations by a liquid array. , 2011, Journal of virological methods.

[3]  A. M. Ismail,et al.  Antiviral Resistance Mutations and Genotype-Associated Amino Acid Substitutions in Treatment-Naïve Hepatitis B Virus-Infected Individuals from the Indian Subcontinent , 2011, Intervirology.

[4]  F. Fregonese,et al.  Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Iain J. MacLeod,et al.  Ultrasensitive detection of minor drug-resistant variants for HIV after nevirapine exposure using allele-specific PCR: clinical significance. , 2010, AIDS research and human retroviruses.

[6]  S. Hammer,et al.  Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients. , 2010, The Journal of infectious diseases.

[7]  Roger Paredes,et al.  Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure. , 2010, The Journal of infectious diseases.

[8]  Jihyun Kim,et al.  Highly sensitive PNA array platform technology for single nucleotide mismatch discrimination. , 2010, Journal of microbiology and biotechnology.

[9]  R. Stadhouders,et al.  The effect of primer-template mismatches on the detection and quantification of nucleic acids using the 5' nuclease assay. , 2010, The Journal of molecular diagnostics : JMD.

[10]  G. Magiorkinis,et al.  Quantitative Detection of the M204V Hepatitis B Virus Minor Variants by Amplification Refractory Mutation System Real-Time PCR Combined with Molecular Beacon Technology , 2009, Journal of Clinical Microbiology.

[11]  Wen-Tso Liu,et al.  Quantitative effects of position and type of single mismatch on single base primer extension. , 2009, Journal of microbiological methods.

[12]  C. Mazzucco,et al.  Ultrasensitive Genotypic Detection of Antiviral Resistance in Hepatitis B Virus Clinical Isolates , 2009, Antimicrobial Agents and Chemotherapy.

[13]  T. Luedde,et al.  The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen–positive and hepatitis B e antigen–negative hepatitis B virus strains , 2009, Hepatology.

[14]  Jörg Petersen,et al.  EASL Clinical Practice Guidelines: management of chronic hepatitis B. , 2009, Journal of hepatology.

[15]  Alessandro Bruselles,et al.  Use of Massively Parallel Ultradeep Pyrosequencing To Characterize the Genetic Diversity of Hepatitis B Virus in Drug-Resistant and Drug-Naive Patients and To Detect Minor Variants in Reverse Transcriptase and Hepatitis B S Antigen , 2008, Journal of Virology.

[16]  H. Tillmann,et al.  Telbivudine versus lamivudine in patients with chronic hepatitis B. , 2008, The New England journal of medicine.

[17]  K. Borroto-Esoda,et al.  Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials. , 2007, Journal of hepatology.

[18]  E. Keeffe,et al.  Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[19]  Angeline Bartholomeusz,et al.  Antiviral drug‐resistant HBV: Standardization of nomenclature and assays and recommendations for management , 2007, Hepatology.

[20]  C. Mazzucco,et al.  Entecavir resistance is rare in nucleoside naïve patients with hepatitis B , 2006, Hepatology.

[21]  R. Hruban,et al.  LigAmp for sensitive detection of single-nucleotide differences , 2004, Nature Methods.

[22]  P. Angus,et al.  Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine , 2004, Antimicrobial Agents and Chemotherapy.

[23]  M. Yuen,et al.  Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy , 2001, Hepatology.

[24]  J. Dienstag,et al.  Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine. , 1999, The Journal of infectious diseases.

[25]  K. Walters,et al.  Identification and characterization of mutations in hepatitis B virus resistant to lamivudine , 1998 .

[26]  K. Walters,et al.  Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. , 1998, Hepatology.

[27]  G. Boiteau,et al.  J. Virol. Methods , 1996, Journal of Virological Methods.

[28]  M. Loeffelholz,et al.  PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid , 1994, Journal of clinical microbiology.